China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 10, 2023 at 03:27 am EST
Share
China Chemical & Pharmaceutical Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 2,095.57 million compared to TWD 2,075.68 million a year ago. Net income was TWD 56.96 million compared to TWD 126.79 million a year ago. Basic earnings per share from continuing operations was TWD 0.19 compared to TWD 0.43 a year ago. Diluted earnings per share from continuing operations was TWD 0.19 compared to TWD 0.42 a year ago.
For the nine months, sales was TWD 6,298.6 million compared to TWD 6,136.6 million a year ago. Net income was TWD 210.14 million compared to TWD 370.56 million a year ago. Basic earnings per share from continuing operations was TWD 0.71 compared to TWD 1.25 a year ago. Diluted earnings per share from continuing operations was TWD 0.7 compared to TWD 1.24 a year ago.
CHINA CHEMICAL & PHARMACEUTICAL CO., LTD. is a Taiwan-based company principally engaged in the manufacture and sales of pharmaceuticals. The products of the Company include pharmaceuticals for human, animal drugs, medical devices, daily products and nutritious food products. Pharmaceuticals for human include prescription drugs and patented medicines, among others. Medical equipment includes nursing liquid for contact lens, sphygmomanometers and manmade joints. Animal drugs include feedstuff additives and healthcare products for animals, among others. Daily products include toothpastes, shower liquid, facial masks and mouth rinses, among others. The Company operates businesses in Taiwan and Mainland China.